SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-094882
Filing Date
2023-04-07
Accepted
2023-04-07 12:20:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d475590ddefa14a.htm DEFA14A 7144
2 GRAPHIC g475590g24h17.jpg GRAPHIC 210576
3 GRAPHIC g475590g44j96.jpg GRAPHIC 390552
  Complete submission text file 0001193125-23-094882.txt   836434
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38997 | Film No.: 23808277
SIC: 2834 Pharmaceutical Preparations